IMMUNOSTAINING OF LEWIS X IN CELLS FROM VOIDED URINE, CYTOPATHOLOGY AND ULTRASOUND FOR NONINVASIVE DETECTION OF BLADDER TUMORS
- 1 February 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 159 (2) , 389-393
- https://doi.org/10.1016/s0022-5347(01)63928-4
Abstract
Purpose: We examined the use of immunostaining of the Lewis X antigen in exfoliated cells from voided urine samples, cytopathology and bladder ultrasound for noninvasive detection of bladde...Keywords
This publication has 8 references indexed in Scilit:
- Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical TreatmentJournal of Urology, 1996
- Detection of bladder tumors by immunostaininc of the lewis x antigen in cells from voided urineUrology, 1995
- Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder CancerJournal of Urology, 1995
- Bladder Tumor Control by Abdominal Ultrasound and Urine CytologyJournal of Urology, 1992
- Enhanced Bladder Cancer Detection with the Lewis X Antigen as a Marker of Neoplastic TransformationJournal of Urology, 1990
- Monoclonal Antibody 486 P 3/12: A Valuable Bladder Carcinoma Marker for ImmunocytologyJournal of Urology, 1987
- Monoclonal Antibodies Against Transitional Cell Carcinoma for Detection of Malignant Urothelial Cells in Bladder WashingJournal of Urology, 1985
- Urine Sediment Smears as a Diagnostic Procedure in Cancers of the Urinary TractScience, 1945